WuXi PharmaTech Recognized in Shanghai for Excellence in Patent Filings
Oct 18, 2004
October 18, 2004 - Shanghai, China - WuXi PharmaTech Co., Ltd., a leading chemistry R&D outsourcing services company, has been selected as one of the "premier research organizations with superior performance in patent filings and intellectual property protection" by the Shanghai Intellectual Property Office in China. A total of thirteen Shanghai-based corporations were recognized, including Huawei Technologies Co., Ltd. and Hutchison Whampoa Limited (HWL). WuXi PharmaTech was selected because of its strong R&D capability in chemistry services and its recent patent filings on behalf of its pharmaceutical and biopharmaceutical customers from around the world. The Shanghai government published this list of outstanding companies to encourage innovation in Shanghai's high-tech industry.
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.